Kathleen Fenn, MD

Assistant Professor of Medicine (Medical Oncology)

DownloadHi-Res Photo

Are You a Patient?

View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

View Doctor Profile

Contact Info

kathleen.fenn@yale.edu

About

Titles

Assistant Professor of Medicine (Medical Oncology)

Biography

Kathleen Fenn, MD is an Instructor of Clinical Medicine (Medical Oncology). Dr. Fenn received her Medical Degree from Yale School of Medicine, and completed her internship and residency at Columbia University Irving Medical Center.

Dr. Fenn is a member of the T32 Cancer Biology Training Program (T32-CA009503) that seeks to identify and recruit individuals with outstanding potential and prepare them for highly productive careers in cancer research. She recently presented at the San Antonio Breast Cancer Symposium on the tumor immune microenvironment in early stage HR-positive/HER2-positive breast cancer.

Appointments

Medical Oncology
Assistant Professor
Primary
Medical Oncology

Education & Training

Fellow: Columbia University Medical Center (2020)

Resident: Columbia University Medical Center (2017)

Intern: Columbia University Medical Center (2015)

MD: Yale School of Medicine (2014)

BS: Yale University, Molecular Biophysics & Biochemistry

Research

Overview

ORCID
0000-0001-6327-4365

Publications

2022

Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer
Zeleke T, Pan Q, Chiuzan C, Onishi M, Li Y, Tan H, Alvarez M, Honan E, Yang M, Chia P, Mukhopadhyay P, Kelly S, Wu R, Fenn K, Trivedi M, Accordino M, Crew K, Hershman D, Maurer M, Jones S, High A, Peng J, Califano A, Kalinsky K, Yu J, Silva J. Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer. Nature Cancer 2022, 4: 257-275. PMID: 36585452, PMCID: PMC9992270, DOI: 10.1038/s43018-022-00489-5.
Peer-Reviewed Original Research
MeSH Keywords and Concepts

2020

Diagnosis of leptomeningeal metastasis (LM) through identification of circulating tumor cells (CTCs) in cerebrospinal fluid (CSF).
Fenn K, Singh V, Lee S, Cieremans D, Lassman A, Hershman D, Crew K, Accordino M, Trivedi M, Iwamoto F, Schultz R, Huynh L, Sales E, Fisher D, Mayer J, Kreisl T, Kalinsky K. Diagnosis of leptomeningeal metastasis (LM) through identification of circulating tumor cells (CTCs) in cerebrospinal fluid (CSF). Journal Of Clinical Oncology 2020, 38: 3567-3567. DOI: 10.1200/jco.2020.38.15_suppl.3567.
Peer-Reviewed Original Research
Concepts

2015

Survival in veterans with lung cancer: Cancer cachexia and the importance of weight.
Malhotra S, Huang K, Simeunovic K, Vinnakota R, Gavrancic T, Villanueva N, Dietz D, Fenn K, Beck K, Coker C, Park Y, Acharyya S. Survival in veterans with lung cancer: Cancer cachexia and the importance of weight. Journal Of Clinical Oncology 2015, 33: e20608-e20608. DOI: 10.1200/jco.2015.33.15_suppl.e20608.
Peer-Reviewed Original Research

Clinical Trials

Current Trials

Phase 2 Study of Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory CD30 Positive T-cell Lymphoma
HIC ID2000029793RoleSub InvestigatorPrimary Completion Date04/30/2028
Recruiting Participants
Lymphoma
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
HIC ID2000032279RoleSub InvestigatorPrimary Completion Date12/31/2033
Recruiting Participants
Prostate Cancer
An Open-Label Phase II Trial to Evaluate the Efficacy and Safety of Neoadjuvant Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel Plus Trastuzumab and Pertuzumab in Early Stage HER2-Negative Breast Cancer Patients Selected With a Test Measuring Live Cell HER2 Signaling Transduction (FACT 1)
HIC ID2000025449RoleSub InvestigatorPrimary Completion Date10/30/2023
Recruiting Participants
Breast Cancer
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
HIC ID2000031542RoleSub InvestigatorPrimary Completion Date01/31/2026
Recruiting Participants
Pancreatic Cancer
SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 Multi-Institution Randomized Prospective Clinical Trial Evaluating the Impact of Cytoreductive Radical Prostatectomy Combined With Best Systemic Therapy on Oncologic and Quality of Life Outcomes in Men With Newly Diagnosed Metastatic Prostate Cancer
HIC ID2000031290RoleSub InvestigatorPrimary Completion Date10/31/2024
Recruiting ParticipantsGenderMaleAge18+ years
Prostate Cancer

See All Current Clinical Trials

Clinical Care

Overview

Medical Oncology

Fact Sheets

Gestational Trophoblastic Tumors
Learn More on Yale Medicine
Hormonal Therapy for Cancer
Learn More on Yale Medicine
Breast Cancer
Learn More on Yale Medicine
Cancer
Learn More on Yale Medicine

See All Fact Sheets On Yale Medicine

Board Certifications

Hematology (Internal Medicine)
Certification Organization
AB of Internal Medicine
Original Certification Date
2021
Medical Oncology
Certification Organization
AB of Internal Medicine
Original Certification Date
2020
Internal Medicine
Certification Organization
AB of Internal Medicine
Original Certification Date
2017

Yale Medicine News

See All News On Yale Medicine

View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

View Doctor Profile

News & Links

News

See All News

Related Links
- Smilow Shares Breast Cancer Awareness: Empowered through Knowledge, Smilow at Trumbull

Get In Touch

Contacts

kathleen.fenn@yale.edu

Appointment Number

203.502.8400

Locations

Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
See Patient Care Locations

Are You a Patient?

Contact Info

Titles

Biography

Appointments

Medical Oncology

Other Departments & Organizations

Education & Training

Overview

ORCID

Publications

2022

2020

2015

Clinical Trials

Current Trials

Overview

Clinical Specialties

Fact Sheets

Gestational Trophoblastic Tumors

Hormonal Therapy for Cancer

Breast Cancer

Cancer

Board Certifications

Hematology (Internal Medicine)

Medical Oncology

Internal Medicine

Yale Medicine News

Are You Iron Deficient? 8 Things Women Should Know

How Fetal Anemia Is Diagnosed and Monitored

Are You a Patient?

News

Smilow Shares Breast Cancer Awareness: Empowered through Knowledge, Smilow at Trumbull

Gynecologic Oncology Specialty Team at Smilow Cancer Hospital Care Center in Trumbull

Smilow Shares in Trumbull: Advances in Breast Cancer Care

Smilow Cancer Hospital Care Centers at Trumbull and Fairfield

Related Links

Contacts

Locations

Patient Care Locations